AGP (KAR:AGP) ROE % Adjusted to Book Value: 7.39% (As of Mar. 2026)


KAR:AGP AGP Ltd KAR:AGP
96 GF Score
Price ₨217.93
GF Value ₨187.66
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is AGP ROE % Adjusted to Book Value?

AGP KAR:AGP +0.31% 96 ROE % Adjusted to Book Value is 7.39% as of Mar. 2026. GuruFocus rates KAR:AGP with a GF Score™ of 96/100 and a GF Value™ of ₨187.66 (Modestly Overvalued). The stock has 4 warning signs investors should review.

AGP's ROE % for the quarter that ended in Mar. 2026 was 21.57%. AGP's PB Ratio for the quarter that ended in Mar. 2026 was 2.92. AGP's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 7.39%.

AGP ROE % Adjusted to Book Value Related Terms

AGP ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for AGP's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AGP ROE % Adjusted to Book Value Chart

AGP Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.95 8.97 8.28 6.05 7.03

AGP Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.61 4.53 7.56 9.07 7.39

KAR:AGP vs ZTS, UTHR, VTRS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, AGP's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AGP ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AGP's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where AGP's ROE % Adjusted to Book Value falls into.


KAR:AGP
96GF Score
AGP Ltd KAR:AGP
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AGP ROE % Adjusted to Book Value Calculation

AGP's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=25.87% / 3.68
=7.03%

AGP's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=21.57% / 2.92
=7.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 7.39% mean?
AGP (KAR:AGP) has a ROE % Adjusted to Book Value of 7.39% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on AGP and its competitors.
Is AGP's ROE % Adjusted to Book Value too high?
AGP's current ROE % Adjusted to Book Value is 7.39%. Overall, AGP has a GF Score™ of 96/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AGP's ROE % Adjusted to Book Value compare to ZTS and UTHR?
AGP's ROE % Adjusted to Book Value of 7.39% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on AGP and its competitors. AGP's current ROE % Adjusted to Book Value is 7.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AGP stock overvalued right now?
Based on GuruFocus' analysis, AGP (KAR:AGP) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨187.66, compared to a current price of ₨217.93 — trading 16.1% above its estimated fair value. The current ROE % Adjusted to Book Value is 7.39%. AGP's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For AGP (KAR:AGP), the current ROE % Adjusted to Book Value is 7.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AGP (KAR:AGP) Overvalued in 2026?

Based on GuruFocus' analysis, AGP stock appears to be overvalued. The current stock price of ₨217.93 is trading 16.1% above its estimated GF Value™ of ₨187.66. GuruFocus considers AGP to be Modestly Overvalued.

Key valuation signals for KAR:AGP:

  • ROE % Adjusted to Book Value: 7.39%
  • GF Value™: ₨187.66 vs. price of ₨217.93 (16.1% above fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the KAR:AGP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AGP Business Description

Address B-23C, S.I.T.E, Karachi, PAK, 75700
AGP Ltd is a pharmaceutical company engaged in the manufacturing and marketing of products under licensing arrangements with other pharmaceutical companies. The company has two manufacturing facilities situated in the S.I.T.E industrial area, Karachi, Pakistan. Its key products include Nergab, Afdol, Nebcin, and others.
96GF Score

Get the complete analysis for KAR:AGP

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨217.93
Price
₨187.66
GF Value